Stay updated on SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Sign up to get notified when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.

Latest updates to the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page
- ChecktodayChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record page continues to display a 403 error.SummaryDifference1%

- Check7 days agoChange DetectedThe footer’s site revision number changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedAccess to the study record page now results in a 403 Forbidden error. The page displays a standard error message and site chrome, indicating an access restriction rather than a content update.SummaryDifference18%

- Check56 days agoChange DetectedThe page revision changed from v3.6.5 to v3.6.6, indicating a new build of the page. This appears to be a minor update, not affecting the trial details or eligibility information.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor update to the page’s versioning information without altering study details or visible content.SummaryDifference0.1%

Stay in the know with updates to SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.